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A B S T R A C T
Introduction: The aim of the study was to propose the Clinical Inventory of Sleep Quality (CISQ), and
compared it with the Pittsburgh sleep quality index (PSQI).
Methods: We studied 400 subjects with the CISQ. Cronbach’s alpha coeﬃcient was calculated to measure the
reliability, and to determine the concurrent validity, a Canonical correlation analysis was performed. At next, we
used an exploratory and conﬁrmatory Factorial analysis with Varimax rotation for validity construct calculation.
Results: Cronbach alpha coeﬃcient of the scale was signiﬁcantly strong (α=0.81). Canonic correlation
was=0.93, suggesting that data proved that the CISQ and PSQI are measuring identical subject. Conﬁrmatory
Factorial analysis model grouped items of the scale in four factors: 1. Daytime symptoms, 2. Nocturnal
symptoms, 3. Sleep disordered breathing symptoms, and 4. Sleep-related movement disorders symptoms. We
proposed ﬁve categories to score CISQ in a range of 0–52 points, as follows: Good quality of sleep, Mild bad
sleep quality, Moderate bad sleep quality, Severe bad sleep quality, and Profound bad sleep quality.
Conclusion: CISQ is a promising tool to measure sleep quality and deserve more research to conﬁrm its utility.
1. Introduction
Clinical scales are useful constructs for evaluation of several
behaviors for human beings. Quality of life (QoL) is an important issue
measured by several scales for mental health of subjects. QoL has been
used for measure associated issues related to cancer [1], depression
and anxiety disorders [2], disability [3], among others. QoL in sleep has
been measured by few instruments [4–6], and there is a need of
clinicians for more scales as a tools in their arsenal to search for QoL in
patients with sleep disorders. Currently, although there are many scales
to measure sleep disorders, some authors had suggested that there is a
need to measure sleep disorders in alternative ways [7], because there
is no perfect tool that can be used in every circumstance.
Sleep quality (SQ) is a very important measurement to weight QoL,
because rest and recovery are among the most important functions of
sleep. Several measurements of SQ had been designed. The most
frequent worldwide used scale for SQ, is the Pittsburgh sleep quality
index (PSQI) [4]. Although PSQI is widely used in sleep medicine, we
believe that its use had some limitations, because: (1) The result of the
index, only indicates good or poor SQ and does not establish diﬀerent
levels of severity of sleep deﬁciency, (2) Its rating sometimes is
complicated if examiner have no experience with the questionnaire,
(3) Although PSQI was translated into the Spanish language and
validated with psychiatric patients [8], and in other languages such
as French [9], and others, some authors had reported that its internal
consistency have no reach the level recommended for individual
comparison [10].
For these reasons is important to develop more instruments for SQ
measurement in other languages, such as Spanish. Thus, in this study,
our objective was to propose and test the Clinical Inventory of Sleep
Quality (CISQ), a novel developed instrument to measure SQ, and
analyze its psychometric properties.
2. Material and methods
2.1. Subjects
We included 400 subjects divided in two groups: the ﬁrst group was
constructed with citizens from Xalapa City in Veracruz State and from
the Clinic of Sleep Disorders in Mexico City, in Mexico, they were the
http://dx.doi.org/10.1016/j.slsci.2016.10.002
Received 21 November 2015; Received in revised form 27 September 2016; Accepted 14 October 2016
Peer review under responsibility of Brazilian Association of Sleep.
⁎ Corresponding author.
1 Dr. Balmis 148, Col. Doctores, Deleg. Cuauhtémoc, 06720, Mexico City, México.
E-mail address: drdislexia@yahoo.com.mx (A. Poblano).
Sleep Science 9 (2016) 216–220
Available online 20 October 2016
1984-0063/ © 2016 Brazilian Association of Sleep. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).
MARK
individuals from the asymptomatic group (n=258, 166 came from
Xalapa, and 92 were healthy volunteers from Mexico City). For the
second group, we studied 142 patients from the Clinic of Sleep
Disorders with mild-moderate Obstructive sleep apnea-hypopnea
syndrome (OSAHS). Exclusion criteria were chronic non-controlled
illness, and illiteracy evaluated by the school degree. All subjects were
studied by means of a general clinical examination, with CISQ, and
PSQI. Mean age of the complete sample was 34.96 years of age, range
18–81 years, 53% were females, and 47% were males. Citizens from
Xalapa City and Mexico City had a mean age of 31.94 years of age, 48%
were females, and 52% males. Patients from the Clinic of Sleep
Disorders had a mean age of 42.42 years of age, 60% were females,
and 40% were males. Research protocol was approved by the Ethics
and Research Boards of the participant institutions, and the research
followed principles of the Declaration of Helsinki. Informed consent
was obtained from all individual participants included in the study.
2.2. Clinical Inventory of Sleep Quality (CISQ)
The CISQ consists of twenty questions in Spanish (see Appendix 1
and 2). The scale is self-administered, instructions for its use was given
by the specialist in Sleep medicine, the estimated time to ﬁll out the
questionnaire was around 10 min. The questionnaire was constructed
based on clinical queries used by clinicians and researchers in the
Clinic of Sleep Disorders, taking into account the PSQI. From 200
questionnaires answered by college students, we identiﬁed the more
predictive items for SQ measurement by means of a logistic regression.
Afterward, we constructed a pilot questionnaire, and eliminated
confused questions, items number one, two and four were joined to
measure “Sleep eﬃciency” (SE), to construct the ﬁnal version of the
CISQ. SE was calculated dividing: number of sleep hours/time in
bed×100. Each question had ﬁve possible answers, from 0 to 4 points
(see Table 1). In the end, we obtained a Total score, where low scores
indicate a good SQ, while higher scores indicate a poor SQ.
2.3. Pittsburgh sleep quality index (PSQI)
This questionnaire includes 19 items comprising seven equally
weighted components: subjective sleep quality (1 item), sleep latency
(2 items), sleep duration (1 item), sleep eﬃciency (3 items), sleep
disturbances (9 items), day-time dysfunction (2 items) and sedative
usage (1 item). The seven components were summed to obtain a single
global PSQI score, with a possible scale range score from 0 to 21. A
global score > 5 indicates a poor SQ. The PSQI was used as standard
reference of the CISQ usefulness.
2.4. Statistical analysis
We calculated average (x) and Standard deviation (SD) of quanti-
tative variables, and percentages (%) of qualitative variables. We used
the Pearson’s correlation coeﬃcient to weight strength and direction of
correlation of each item of the CISQ. We used the Cronbach’s alpha
coeﬃcient to determine internal consistency [11], and the Canonic
correlation analysis to determine the Concurrent validity of the scale,
comparing CISQ with PSQI. We used an Exploratory factorial analysis
with a Varimax rotation to weight the items of questionnaire and a ﬁnal
Conﬁrmatory factorial analysis for construct validity. An alpha value of
p≤0.05 was selected to accept measurements as signiﬁcant.
3. Results
Mean of the total score of CISQ was 15.78 ± 8.47, in asymptomatic
subjects CISQ had a mean total score of 6.34 ± 3.29, PSQI in
asymptomatic subjects was 5.66 ± 2.47. Diﬀerences between average
in the CISQ of sample from Xalapa City-Mexico City and from the
Clinic of Sleep Disorders was signiﬁcant (mean total score of asympto-
matic group of citizens from Xalapa City and Mexico City was 12.57
while patients from clinic was 21.60, t=−11.84, p < 0.001). Cronbach
alpha coeﬃcient of the scale, was signiﬁcantly strong (α=0.81).
Correlation coeﬃcients of each questions of the questionnaire vs the
total score of CISQ is showed in Table 2. We eliminated the following
questions because had lower values in the Correlation analysis: How
long it takes to sleep?, How many nights do you have insomnia?, How
many nights a week do you have nightmares?, How many nights a week
do you have taken a drug for sleep?, How many hours do you sleep?,
What score give you to your sleep quality?, the last couple of questions
because they are closely related with sleep eﬃciency and subjective
quality of sleep, respectively. Comparison of CISQ with PSQI by means
of Canonic correlation was signiﬁcantly strong (0.93).
In the Exploratory factorial analysis, we examined the correlation
matrix with the Sphericity test of Bartlett and measured sample
adequacy by Kaiser-Meyer-Olkin test, which showed a strong correla-
Table 1
Possible answer and scoring of each question of the Clinical Inventory of Sleep Quality (CISQ).
Questions Score
0 1 2 3 4
Sleep eﬃciency 100–90% 89–80 79–70 69–60 < 60%
How long it takes to sleep? < 15 min 16–30 31–45 46–60 > 60 min
How many hours do you sleep? 7–8 6 or 9 5 or 10 4 or 11 3 or 12
How many nights do you wake up once slept? 0 1 2 3 4
What score give you to your sleep quality? 10–9 8–7 6–5 4–3 2–1
How do you consider your sleep quality? Very good Good Fair Bad Very bad
Questions 5, 6, 8, 9, 11, 12, 13, 14, 16, 17, 18, 19, 20 0 nights/week 1–2 nights/week 3–4 nights/week 5–6 nights/week ≥7 nights/week
Table 2
Correlation of each questions vs the Total score of the Clinical Inventory of Sleep Quality.
Question r No. of variables
1. Sleep eﬃciency 0.52 12
2. How long it takes to sleep? 0.39 9
3. How many hours do you sleep? 0.41 9
4. How many nights do you have insomnia? 0.24 6
5. How many nights do you have diﬃculties to sleep? 0.59 15
6. How many nights do you wake up once slept? 0.47 13
7. How many nights a week do you wake up once slept? 0.48 14
8. How many nights a week do you have nightmares? 0.28 9
9. What score give you to your sleep quality? 0.64 18
10.How many mornings do you have diﬃculties for wake-up? 0.46 8
11.How many mornings do you wake up tired? 0.65 15
12.How many days you have the need to sleep at a day? 0.55 10
13.How many days do you have malaise? 0.72 17
14.How do you consider your sleep quality? 0.79 18
15.How many nights do you have restless legs? 0.46 11
16.How many nights do you wake up with cramps? 0.43 12
17.How many nights do you snore? 0.47 12
18.How many nights do you have breathing pauses? 0.41 9
19.Do you have taken a drug for sleep? 0.34 9
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tion (0.81), needed for factorial analysis. We selected factors using the
Maximum likelihood estimation, and supported in this measurement,
we chose three factors for analysis. Factor one, explains 32% of
variance, factor two explains 14%, and factor three explains 9%. In
overall, variance explained by the three factors was 56%.
The next step was to identify variables of each question for each
factor. We used a Varimax rotation to identify each variable in a
particular factor. Factorial weights of each item are presented in
Table 3 grouped in the three factors, as follows: 1. Daytime symptoms,
2. Nocturnal symptoms, 3. Respiratory alterations. We built a Model of
covariance structures identifying: number of common factors, number
of observed variables, links between common factors, relationships
among observed variables and common factors, from each factor and
observed variables, and from each factor to the others. We designed a
diagram of sequences with the relationship of causality among factors
and observed variables. We calculated the Maximum likelihood esti-
mation and identiﬁed violator variables with coeﬃcients near or over
1.0. Because we have several infringing variables, we proposed a new
model for the Conﬁrmatory factorial analysis. The new model was
grouped in four factors: 1. Daytime symptoms, 2. Nocturnal symptoms,
3. Sleep disordered breathing symptoms (SDBS), and 4. Sleep related
movement disorders symptoms (SRMDS). Table 4 shows model
estimation. As can be observed in table, there are no infractions, all
variances are positive, standardized coeﬃcients are < 1.00, and
standard errors are low.
We calculated measures of Goodness of ﬁt of the Conﬁrmatory
factorial analysis, and showed in Table 5. We observed good scores in
all measures, which conﬁrm usefulness of the CISQ. We obtained the
Construct reliability, and Variance measurements presented in Table 6
and Fig. 1. The four constructs are over the suggested reliability level
(0.70), and near of suggested variance level (0.50). In base of our
results, we proposed a 13 items questionnaire, divided in ﬁve classi-
ﬁcation categories, in a range of 0–52 points, and excluding questions
that no contributed to analysis, as follows: Good quality of sleep=0–10,
Mild bad sleep quality=11–15, Moderate bad sleep quality=16–22,




Our main contribution was to propose and validate the CISQ as a
new tool. The questionnaire presents several advantages for Spanish
speaking population due is easier to use, to score, and interpret,
because has few items, allows a well deﬁned cut-point, and provide
severity levels that deﬁned bad SQ. CISQ proved to be a consistent
tests, because had a high Cronbach alpha score. Concurrent validity
found by means of Canonic correlation was high, which indicates that
CISQ has a good validity and its content really measure SQ. We
proposed ﬁve levels for interpretation the total score: good SQ, bad SQ
of mild intensity, bad SQ of moderate intensity, bad SQ of severe
intensity, and bad SQ of profound intensity.
4.2. Clinical utility
Sleep medicine is an emergent medical speciality in several
Spanish-speaking countries. Sleep alterations have a high prevalence
in these developing countries [12], thus, these populations are in need
for alternative screening and diagnostic tools for sleep alterations [13].
None questionnaire or subjective scale is free from biases, thus we
should always look for improved tools. There are some articles
providing caveats and drawbacks on the use of PSQI, some problems
with PSQI are based and argued solely on subjectivity of opinions and
perceptions of the responders [10]. The questionnaire proposed here,
includes four important areas of sleep problems, such as: daytime
symptoms, nocturnal symptoms, sleep breathing disorders, and sleep
Table 3




Diﬃculty for wake-up 0.573
Sleepiness 0.752
Malaise 0.617 0.454
Subjective quality 0.595 0.493
Diﬃculty for sleep 0.547
Awakenings at night 0.513







Factorial weights of each item.




X2 0.74 0.06 11.63 < .001 0.17
X3 0.88 0.06 14.18 < .001 0.87
X4 0.62 0.05 11.43 < .001 0.56




X7 0.83 0.08 9.317 < .001 1.00
X8 0.63 0.06 9.549 < .001 0.54
X9 0.92 0.09 9.560 < .001 1.12
X4 0.50 0.07 6.998 < .001
X5 0.62 0.06 9.547 < .001
SDB symptoms X10 1.00 0.46
X11 0.86 0.14 6.047 < .001 1.27
SRMD symptoms X12 1.00 0.18
X13 0.64 0.09 6.811 < .001 0.29
SE=Standard error. p=probability. SDB=Sleep disordered breathing. SRMD=Sleep
related movement disorders.
Table 5
Measures of Goodness of fit.
n = 400
Goodness of ﬁt index 0.95
Crossed validation index 0.45
Measures of incremental adjust
Adjusted Goodness of ﬁt index 0.93
Tucker–Lewis index 0.95
Index of non-normed ﬁt 0.95
Index of normed ﬁt 0.93
Measures of parsimony adjust
Normed ﬁt of parsimony index 0.68
Akaike criteria of information 14635.14
Comparative ﬁt index 0.96
Incremental ﬁt index 0.96
Relative ﬁt index 0.90
Table 6
Measurement of Construct reliability and Variance of model adjusted.
Construct Reliability Variance
Daytime symptoms 0.82 0.48
Insomnia eﬀects 0.76 0.36
Respiratorios alterations 0.72 0.57
Movements alterations 0.76 0.62
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related movement alterations. Thus, we believe that CISQ had a broad
space to ﬁll and some advantages over PSQI.
4.3. Comparison with other studies
Mollayeva et al. reviewed the properties of the PSQI, searching for
its potential as a screening tool for sleep dysfunction in non-clinical
and clinical samples, authors reviewed several studies: 22 examined
construct validity, 19 known-group validity, 15 internal consistency,
and three test-retest reliability. Internal consistency, based on
Cronbach’s alpha, was good; discrepancies were observed in factor
analytic studies; in non-clinical and clinical samples with known
diﬀerences in sleep quality, the PSQI global scores and all subscale
scores, with the exception of sleep disturbance, which diﬀered sig-
niﬁcantly. The best evidence for the PSQI showed strong reliability and
validity, and moderate structural validity in a variety of samples,
suggesting the tool can be improved [10].
There are no other studies in search of CISQ usefulness, however,
validation of PSQI in Spanish had deserved some studies. In example,
Escobar-Cordova and Eslava-Schmalbach validated PSQI use in
Colombia, they observed that evaluation of internal consistency was
signiﬁcant (Cronbach's alpha=0.78), there were diﬀerent scores be-
tween subjects that mentioned some subjective sleep disturbance, and
between them in which qualify were “so bad” or not, in their SQ, and
among those that were consuming or not, habitually hypnotics and
between those that referred conciliation insomnia or not. There were
clinical diﬀerences in PSQI scores between adults older and younger.
Authors observed no diﬀerences by gender [14].
Jimenez-Genchi et al. studied eighty seven psychiatric patients
without treatment and 48 control subjects, who underwent psychiatric
structured assessment and completed the PSQI. There were no
signiﬁcant diﬀerences between psychiatric patients and control sub-
jects on age and gender. The PSQI displayed a satisfactory Reliability
coeﬃcient (0.78) and components of total score correlations were all
signiﬁcant (0.53–0.77). The PSQI showed two main factors: sleep
duration and sleep quality. Patients obtained signiﬁcantly higher scores
than controls, in both the global and the component scores, with the
exception of sleep duration. The PSQI scores were not signiﬁcantly
diﬀerent between males and females and were not associated with age
[8].
Thus, in both above quoted studies, validation of the use of PSQI in
Spanish speaking populations was carried-out. Other studies had
validates use of PSQI in QoL for sleep apnea [15], and sleep quality
in ﬁbromyalgia [16] as an example of the need of SQ measurements. At
last, despite the article has been written in English, CISQ was
developed and used in Spanish populations.
4.4. Limitations of the study
The number of studied patients in short, the observation had a
cross-sectional design instead a prospective follow-up, however the
observation is valious and conclusions are valid for the target popula-
tion. On the other hand, it is important to state clearly that the
questionnaire is validated only for its use on Spanish speaking patients.
Future observations overcome these limitations.
5. Conclusions
Comparison of CISQ with PSQI by means of Canonic correlation
was signiﬁcantly strong, this proves us that the two measurement
procedures are measuring identical subject construct. CISQ is a
promising tool to measure sleep quality and deserve more research
to conﬁrm its utility.
Appendix A. Supplementary material
Supplementary data associated with this article can be found in the
online version at http://dx.doi.org/10.1016/j.slsci.2016.10.002.
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